Janus Henderson Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Sell
25,021
-1,142
-4% -$105K ﹤0.01% 1291
2025
Q4
$2.35M Sell
26,163
-2,449
-9% -$232K ﹤0.01% 1262
2025
Q3
$2.82M Sell
28,612
-95,006
-77% -$9.41M ﹤0.01% 1165
2025
Q2
$11.3M Sell
123,618
-114,001
-48% -$11M 0.01% 696
2025
Q1
$26.7M Buy
237,619
+79,786
+51% +$8.54M 0.01% 503
2024
Q4
$16.7M Sell
157,833
-1,644
-1% -$176K 0.01% 623
2024
Q3
$17.2M Buy
159,477
+134,931
+550% +$14.7M 0.01% 600
2024
Q2
$2.66M Sell
24,546
-3,982
-14% -$469K ﹤0.01% 1121
2024
Q1
$3.76M Sell
28,528
-1,197
-4% -$150K ﹤0.01% 989
2023
Q4
$3.62M Sell
29,725
-36,963
-55% -$4.12M ﹤0.01% 955
2023
Q3
$7.48M Buy
66,688
+37,762
+131% +$4.8M ﹤0.01% 722
2023
Q2
$4.21M Sell
28,926
-2,009
-6% -$273K ﹤0.01% 910
2023
Q1
$3.99M Buy
30,935
+6,602
+27% +$829K ﹤0.01% 948
2022
Q4
$3.1M Sell
24,333
-24,337
-50% -$2.82M ﹤0.01% 980
2022
Q3
$5.1M Buy
48,670
+22,434
+86% +$2.46M ﹤0.01% 993
2022
Q2
$2.76M Sell
26,236
-120,517
-82% -$14.3M ﹤0.01% 964
2022
Q1
$18.8M Sell
146,753
-181,064
-55% -$21.8M 0.01% 760
2021
Q4
$40.4M Buy
327,817
+285,323
+671% +$37.3M 0.02% 619
2021
Q3
$6.04M Sell
42,494
-108,992
-72% -$16M ﹤0.01% 1013
2021
Q2
$23.7M Sell
151,486
-102,658
-40% -$16.6M 0.01% 751
2021
Q1
$39.5M Buy
254,144
+24,526
+11% +$3.8M 0.02% 610
2020
Q4
$34.4M Buy
229,618
+88,318
+63% +$12.5M 0.02% 630
2020
Q3
$18.7M Buy
141,300
+19,700
+16% +$2.57M 0.01% 723
2020
Q2
$14.1M Sell
121,600
-14,198
-10% -$1.64M 0.01% 765
2020
Q1
$13.3M Buy
135,798
+67,576
+99% +$8.86M 0.01% 768
2019
Q4
$9.91M Sell
68,222
-19,265
-22% -$2.66M 0.01% 954
2019
Q3
$11.7M Sell
87,487
-3,922
-4% -$507K 0.01% 920
2019
Q2
$10.4M Buy
91,409
+17,127
+23% +$2.01M 0.01% 938
2019
Q1
$9.21M Buy
74,282
+19,110
+35% +$2.17M 0.01% 925
2018
Q4
$5.56M Sell
55,172
-1,690
-3% -$190K ﹤0.01% 955
2018
Q3
$7.26M Sell
56,862
-47,158
-45% -$5.61M ﹤0.01% 973
2018
Q2
$11.3M Sell
104,020
-37,335
-26% -$4.06M 0.01% 900
2018
Q1
$15M Buy
141,355
+2,091
+2% +$243K 0.01% 834
2017
Q4
$16.3M Sell
139,264
-16,149
-10% -$1.83M 0.01% 792
2017
Q3
$17.7M Buy
155,413
+16,050
+12% +$1.85M 0.01% 759
2017
Q2
$17.4M Buy
139,363
+69,687
+100% +$8.26M 0.01% 772
2017
Q1
$8.26M Sell
69,676
-21,669
-24% -$2.46M 0.06% 304
2016
Q4
$9.15M Buy
91,345
+10,637
+13% +$1.14M 0.07% 290
2016
Q3
$10.2M Sell
80,708
-1,870
-2% -$231K 0.08% 272
2016
Q2
$9.65M Sell
82,578
-53,883
-39% -$6.1M 0.08% 264
2016
Q1
$14.1M Sell
136,461
-1,661
-1% -$161K 0.11% 212
2015
Q4
$13.8M Sell
138,122
-336
-0.2% -$32.9K 0.11% 210
2015
Q3
$12.6M Buy
138,458
+16,952
+14% +$1.7M 0.11% 215
2015
Q2
$12.9M Sell
121,506
-20,863
-15% -$2.31M 0.1% 228
2015
Q1
$16.2M Buy
142,369
+15,486
+12% +$1.77M 0.13% 208
2014
Q4
$14M Buy
126,883
+38,285
+43% +$4.04M 0.1% 240
2014
Q3
$8.65M Buy
88,598
+804
+0.9% +$79.1K 0.08% 219
2014
Q2
$8.85M Buy
87,794
+65,827
+300% +$6.42M 0.08% 226
2014
Q1
$2.02M Buy
21,967
+3,811
+21% +$351K 0.02% 441
2013
Q4
$1.64M Sell
18,156
-4,442
-20% -$384K 0.02% 449
2013
Q3
$1.8M Sell
22,598
-1,556
-6% -$122K 0.02% 413
2013
Q2
$1.76M Buy
+24,154
New +$1.81M 0.02% 398

Other funds holding ZBH

Janus Henderson Group's ZBH Position: Q1 2026 in Review

Janus Henderson Group reduced its Zimmer Biomet (ZBH) stake by 4.4% in Q1 2026, selling an estimated $105K and leaving 25,021 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Janus Henderson Group first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $40.4M in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Janus Henderson Group held 25,021 shares of Zimmer Biomet worth $2.26M as of Q1 2026.
  • Janus Henderson Group sold 1,142 Zimmer Biomet shares in Q1 2026, an estimated $105K.
  • Zimmer Biomet made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1291 holding.
  • Janus Henderson Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Janus Henderson Group's Zimmer Biomet position peaked at $40.4M in Q4 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.